If you are asking whether magnesium, riboflavin and CoQ10 help with migraines, here is the straight answer: one randomized trial tested a product with that three-ingredient mix against a placebo for three months. People taking it reported bigger improvements in migraine pain and headache impact than the placebo group, but their drop in migraine days was not statistically different from placebo. Most people reach this question on a bad day, so we will start with what the studies found, then show you how to match a label to a trial and what to bring to your headache clinician.
Is CoQ10 riboflavin, and are these the same thing?
No. Riboflavin is vitamin B2. CoQ10 is coenzyme Q10. The Cleveland Clinic migraine guide lists them as separate items, along with magnesium, feverfew and butterbur, among the vitamins, minerals and herbs people use as alternative migraine remedies.
A 2025 headache nutraceutical review on PubMed covers all three ingredients. Its abstract, indexed by the U.S. National Library of Medicine, reports the following:
| Ingredient | What the 2025 review says about prevention | Side effects it reports |
|---|---|---|
| Riboflavin (vitamin B2) | “can be recommended for migraine prevention in adults, but pediatric use is not proven” | “Adverse events are minimal” |
| Coenzyme Q10 (CoQ10) | “Level C evidence for migraine prevention” | “low adverse events” |
| Magnesium | “recommended for migraine prevention and intravenous acute use” | “potential for generally mild gastrointestinal tolerability adverse events” |
Prevention is not the same as stopping an attack. The Cleveland Clinic guide says preventive medicines are taken on a schedule: “You can take these medications as directed, usually on a daily basis.” Medicines for an attack are a separate group.
Were the same ingredients and amounts studied together?
Only partly. The two randomized trials tested different products.
| Study | What was tested | Who took part | What it found |
|---|---|---|---|
| 2004 riboflavin, magnesium and feverfew trial (Headache) | A compound giving riboflavin 400 mg, magnesium 300 mg and feverfew 100 mg daily. The placebo contained 25 mg riboflavin. | 49 patients completed the 3-month trial | Patients with a 50% or greater reduction in migraines: 42% on the active compound and 44% on placebo (P=.87). Both groups improved from baseline. |
| 2015 randomized trial (Journal of Headache and Pain) | A fixed combination of magnesium, riboflavin and Q10. The abstract names the product Migravent in Germany and Dolovent in the USA. | 130 adults with three or more migraine attacks a month, after a 4-week baseline and 3 months of treatment | Migraine days per month went from 6.2 to 4.4 on the supplement and from 6.2 to 5.2 on placebo (p = 0.23). Pain intensity fell more than on placebo (p = 0.03). HIT-6 scores fell 4.8 points, from 61.9 to 57.1, versus 2 points on placebo (p = 0.01). |
The 2015 trial is the closest match to a three-ingredient label. Open the full paper from the PubMed link to find the milligram amount of each ingredient.
The 2004 trial tested a different blend. It included feverfew, and its daily amounts were riboflavin 400 mg and magnesium 300 mg. Its placebo was not empty: it contained 25 mg of riboflavin. The why trials need a placebo group (our research library) guide explains why that design matters.
How to match a label to a trial
- Check whether the label lists all three ingredients: magnesium, riboflavin and CoQ10.
- Check for extra ingredients. The 2004 blend had feverfew, so a label with feverfew is closer to that trial than to the 2015 one.
- Compare the milligram amounts on the label with the amounts in the full paper. Matching names does not mean matching amounts.
- Note the product name. The 2015 trial’s product was sold as Migravent in Germany and Dolovent in the USA, so a different brand is a different test.
Can a single-ingredient study validate a blend?
No. A study of one ingredient tells you about that ingredient. A blend is a separate product with its own trial, and its results depend on the exact mix and amounts. A 2004 review of magnesium, CoQ10, riboflavin and B12 said their potential “can be cautiously inferred from some published open clinical trials,” and that “double-blind randomized larger studies are needed.”
The 2004 blend trial reached the same caution. Its conclusion was: “There is at present conflicting scientific evidence with regard to the efficacy of these compounds for migraine prophylaxis.”
What the studies can and cannot tell you
Migraine is common. The Cleveland Clinic guide says “an estimated 12% of people in the United States experience migraines.” That is why so many people look for options beyond a single medicine.
- The 2015 trial was small, with 130 adults, and ran for 3 months after a 4-week baseline.
- Its main frequency result showed what its authors called “a trend towards statistical significance,” not a clear difference from placebo.
- Its pain and headache-impact results were statistically better than placebo.
- The 2025 review says riboflavin’s pediatric use is not proven, so its riboflavin finding applies to adults.
- The 2025 review notes that nutraceuticals are not regulated by the US Food and Drug Administration, which is why it calls for careful review before clinical decisions.
The studies cannot tell you whether a product on your shelf matches the trial product, how it would work for your migraines over years, or how it compares with prescription preventive medicines. Your clinician can help you weigh those points.
What are the side effects, and who should talk to a clinician first?
The Cleveland Clinic magnesium article gives the most specific magnesium cautions here. It says the recommended upper limit for magnesium from supplements is 350 mg per day for adults, and that you should avoid higher doses unless your healthcare provider recommends them. Taking more than 350 mg per day from supplements can cause diarrhea, nausea and stomach cramps.
| Ingredient | What is reported | Source |
|---|---|---|
| Magnesium (above 350 mg a day from supplements) | “side effects like diarrhea, nausea and stomach cramps” | Cleveland Clinic magnesium article |
| Magnesium | May interact with “certain antibiotics, osteoporosis medications and diuretics” | Cleveland Clinic magnesium article |
| Magnesium | With kidney problems, “magnesium can build up to dangerous levels” | Cleveland Clinic magnesium article |
| Magnesium | Generally mild gastrointestinal tolerability adverse events | 2025 headache nutraceutical review |
| Riboflavin | Adverse events are minimal | 2025 headache nutraceutical review |
| CoQ10 | Low adverse events. Read more in our coenzyme Q10 safety evidence (our research library) guide. | 2025 headache nutraceutical review |
The Cleveland Clinic migraine guide says: “Talk to your healthcare provider before starting any alternative therapies for migraines.” It also says to talk to your provider if you are pregnant or plan on becoming pregnant and have migraines.
What are the other options for migraine prevention?
The Cleveland Clinic guide lists the preventive medicine groups clinicians use: antiseizure medicines (valproic acid, topiramate), beta-blockers (atenolol, propranolol, nadolol), calcium channel blockers (verapamil), monoclonal antibodies (erenumab, fremanezumab, galcanezumab), tricyclic antidepressants (amitriptyline, nortriptyline, doxepin), and serotonin and norepinephrine reuptake inhibitors (venlafaxine, duloxetine). Your clinician decides which, if any, fit you.
Non-drug options in the same guide include relaxation techniques like yoga, acupuncture, biofeedback and Botox injections. The guide also recommends keeping a migraine journal to find your triggers. For more on the magnesium side of this question, read does magnesium help migraines. If you also use magnesium in another form, our magnesium cream side effects guide covers that separately.
What the rules say about these products
In a November 5, 2020 warning letter to Quten Research Institute, the U.S. Food and Drug Administration said that claims on the company’s website made two of its CoQ10 and turmeric products drugs. The letter cites section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act, which covers products intended for use in the mitigation, treatment or prevention of disease. As of October 5, 2026, the letter is posted on the FDA warning letter page. This is information, not legal advice.
Migraine treatment discussion sheet
Bring this list to your headache clinician to prepare a prevention discussion covering your current treatment, all products and how you tolerate them.
- Current treatment: every prescription and over-the-counter medicine, and how often you take each. The Cleveland Clinic guide asks you to tell your provider if you take over-the-counter pain medicine “more than two to three times a week.”
- All products: every vitamin, mineral, herb or supplement, with the amounts from each label. The Cleveland Clinic magnesium article says “It’s important to know what you’re taking, especially if you already take a multivitamin or other supplements.”
- Tolerability: any stomach upset, diarrhea, cramps or other changes since you began a product.
- Track: keep a migraine journal of when each attack starts, how you felt and how long it lasted. Count migraine days each month, the measure the 2015 trial used.
- Safety: the Cleveland Clinic guide says to call 911 or go to an emergency department right away for “the worst headache of your life,” new neurological symptoms, or a headache after a head injury.
Questions to ask at the visit
- Given my current treatment, does a prevention option make sense for me?
- Do any of my products or medicines interact with each other?
- Are the amounts on my labels in line with what you would consider appropriate for me?
- What would you track to tell whether a prevention plan is working, and over what period?
Wording to use at the visit
“I want to talk about preventing migraines, not only treating attacks. Here is my list of every product I take, with the amounts from each label, including magnesium, riboflavin and CoQ10. Here is my migraine journal for the past month.”
Your next step is simple: bring the list and the journal to your next appointment, and let your clinician decide what fits.
By the Pain Care Questions Team
Leave a Reply